fda warning on semaglutide The has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and FDA warns Novo Nordisk of
Description
Sematide Injection Higher-dose injectable for advanced management

GLP-1 medications like semaglutide (Ozempic and Wegovy) are often around weight loss, but the science on long-term health changed my mind.

Fort Smith, AR
But more studies are needed to understand the finding.

However, a side effect that many patients experience is constipation
